Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR

Cudratricusxanthone A exhibits antitumor activity and enhances chemosensitivity to cisplatin against NSCLC via targeting EGFR

Abstract Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and has gained considerable global attention. Epidermal growth factor receptor (EGFR) plays a key role in NSCLC treatment. NSCLC with wild-type EGFR (WT-EGFR) is not responsive to EGFR tyrosine kinase...

Full description

Saved in:
Bibliographic Details
Main Authors: Peiyuan Sun, Zhuoyi Wang, Ruohan Zhang, Xuanyou Li, Boxing Xu, Rui Shen, Jun Sheng, Jing Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
NSCLC
EGFR
Cudratricusxanthone A
Antitumor
Chemosensitivity
Online Access:https://doi.org/10.1038/s41598-025-14889-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-14889-x

Similar Items